Patient Assistance Programs for Symtuza Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Full Answer
Does it cost anything to get started with symtuza ®?
Janssen CarePath has cost support, as well as resources to help you get started and stay on track with SYMTUZA ® . Free 30-day trial supply for eligible patients. With SYMply Start ® Trial Offer you can try SYMTUZA ® at no cost to see if it’s right for you. You must be 12 years of age or older and have a valid, signed 30-day prescription.
What is symtuza?
Symtuza (cobicistat/darunavir/emtricitabine/tenofovir alafenamide) is a member of the antiviral combinations drug class and is commonly used for HIV Infection. This Symtuza price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Is it safe for a child to take symtuza?
Pediatric Use: The safety and effectiveness of SYMTUZA ® have not been established and is not recommended in pediatric patients weighing less than 40 kg. Consult the full Prescribing Information for SYMTUZA ® for additional information on the Uses in Specific Populations.
What should I do if I stop taking symtuza®?
Refill your prescription or talk to your healthcare provider before your SYMTUZA® is all gone. If you stop taking SYMTUZA®, your healthcare provider will need to check your health often and do blood tests regularly for several months to check your HBV infection or give you a medicine to treat your HBV infection.
What is the cost of Symtuza?
The cost for Symtuza oral tablet (150 mg-800 mg-200 mg-10 mg) is around $4,529 for a supply of 30 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
WHAT company makes SYMTUZA?
TITUSVILLE, N.J, JULY 17, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved SYMTUZATM, the first and only complete, darunavir-based single-tablet regimen (STR) for the treatment of human immunodeficiency virus type 1 (HIV-1) in ...
What is Janssen CarePath card for?
Eligible patients pay $5 for each injection with a $20,000 maximum program benefit per calendar year. Card provides instant savings when used with pharmacy/prescription insurance at specialty pharmacy or retail pharmacy.
How does Janssen savings program work?
The Janssen CarePath Savings Program is designed to help lower eligible patients' out-of-pocket medication costs for their Janssen medication. Eligible patients using commercial or private insurance to pay for their Janssen medication will receive savings off their deductible, co-pay, and co-insurance medication costs.
Does Symtuza cause weight gain?
Is weight gain a concern? *Across 2 clinical trials, one patient taking SYMTUZA® experienced treatment-related weight gain. The average weight gain over 48 weeks was between 3.13 lbs (1.42 kg) and 3.84 lbs (1.75 kg) in 1,125 patients in the SYMTUZA® group, and ~1 lb (. 45 kg) for 741 patients in the control group.
How good is Symtuza?
Overall, 75% of patients taking Symtuza (77 patients out of 103) achieved this reduction after 24 weeks of treatment, which was similar to the 74% (37 of 50) of patients who achieved it with the comparator.
Does Janssen have a patient assistance program?
Janssen is committed to helping patients obtain appropriate access to our medicines. We partner with private and public payers and healthcare systems to support availability of our products and we offer and support a variety of programs and services to assist with access to and appropriate use of new treatment options.
Who is Janssen CarePath?
Janssen CarePath is your one source for resources focused on access, affordability, and treatment support for your patients. Our Care Coordinator team supports all the Janssen products you prescribe. We can help make it easier for you and your patients to get the resources you both may need.
Does Janssen CarePath work with Medicare?
If you use commercial or private health insurance, Janssen CarePath Savings Program may help you save on your out-of-pocket costs. Patients using Medicare, Medicaid, or any other federally funded programs to pay for their Janssen medication are not eligible to participate.
Is Janssen part of Johnson and Johnson?
Janssen Pharmaceuticals is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.
What drugs does Janssen make?
Janssen United States > ProductsB. BALVERSA™ (erdafitinib) Full Prescribing Information. ... C. CARVYKTI™ (ciltacabtagene autoleucel; cilta-cel) ... D. DARZALEX FASPRO™ (daratumumab and hyaluronidase-fihj) ... E. EDURANT® (rilpivirine) ... H. HALDOL® (haloperidol) ... I. IMBRUVICA® (ibrutinib) ... O. OPSUMIT® (macitentan) ... P. PONVORY™ (Ponesimod)More items...
Does Janssen CarePath expire?
You must meet the program requirements every time you use the card. Program terms will expire at the end of each calendar year. The program may change or end without notice, including in specific states.
What is the generic name for Symtuza?
Generic Name: darunavir-cobi-emtri-tenof ala This product contains 4 different medications: darunavir, cobicistat, emtricitabine, and tenofovir alafenamide. Darunavir is known as a protease inhibitor. Cobicistat helps darunavir work better.
Can I take Symtuza without food?
You should take Symtuza once a day with food – you should take it within half an hour of having a meal or snack. The tablet should be swallowed whole – don't chew, crush or split it. HIV treatment works best if you take it every day, ideally at the same time each day.
What is the side effects of Symtuza?
The most common side effects of SYMTUZA® are: diarrhea, rash, nausea, fatigue, headache, stomach problems, and gas....SYMTUZA® can cause serious side effects including:Worsening of hepatitis B virus infection. ... Change in liver enzymes.Severe liver problems.
Is Symtuza safe?
SYMTUZA® may cause severe or life-threatening skin reactions or rashes which may sometimes require treatment in a hospital. Call your healthcare provider right away if you develop a rash. Stop taking SYMTUZA® and call your healthcare provider right away if you develop any skin changes with symptoms below: Fever.
What is Symtuza used for?
SYMTUZA ® is a prescription medicine that is used without other antiretroviral medicines to treat Human Immunodeficiency Virus-1 (HIV-1) infection in adults and in children who weigh at least 88 pounds (40 kg) who:
What are the side effects of Symtuza?
The most common side effects of SYMTUZA® are: Diarrhea, rash, nausea, fatigue, headache, stomach problems, and gas. These are not all of the possible side effects of SYMTUZA ® . Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA.
What happens if you stop taking Symtuza?
If you stop taking SYMTUZA®, your healthcare provider will need to check your health often and do blood tests regularly for several months to check your HBV infection or give you a medicine to treat your HBV infection.
What to tell your doctor before taking Symtuza?
Before taking SYMTUZA®, tell your healthcare provider about all of your medical conditions, including if you: have liver problems (including hepatitis B or hepatitis C), have kidney problems, are allergic to sulfa (sulfonamide), have diabetes, have hemophilia, or have any other medical condition.
What happens if you have a yellow eye?
Skin or the white part of your eyes turn yellow. Dark "tea-colored" urine. Light-colored stools. Loss of appetite for several days or longer. Nausea. Vomiting. Stomach area pain. SYMTUZA® may cause severe or life-threatening skin reactions or rashes which may sometimes require treatment in a hospital.
How to report side effects of Janssen?
Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to Janssen Products, LP at 1-800-JANSSEN (1-800-526-7736).
How do you know if you have a heart attack?
Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat.
What is Symtuza used for?
SYMTUZA ® is a prescription medicine that is used without other antiretroviral medicines to treat Human Immunodeficiency Virus-1 (HIV-1) infection in adults and in children who weigh at least 88 pounds (40 kg) who: when their healthcare provider determines that they meet certain requirements.
What to tell your doctor before taking Symtuza?
Before taking SYMTUZA ®, tell your healthcare provider about all of your medical conditions, including if you: have liver problems (including hepatitis B or hepatitis C), have kidney problems, are allergic to sulfa (sulfonamide), have diabetes, have hemophilia, or have any other medical condition.
What happens if you stop taking Symtuza?
If you stop taking SYMTUZA®, your healthcare provider will need to check your health often and do blood tests regularly for several months to check your HBV infection or give you a medicine to treat your HBV infection.
What happens if you have a yellow eye?
Skin or the white part of your eyes turn yellow. Dark "tea-colored" urine. Light-colored stools. Loss of appetite for several days or longer. Nausea. Vomiting. Stomach area pain. SYMTUZA® may cause severe or life-threatening skin reactions or rashes which may sometimes require treatment in a hospital.
How to report side effects of Janssen?
Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to Janssen Products, LP at 1-800-JANSSEN (1-800-526-7736).
Is Symtuza safe for children?
HIV-1 is the virus that causes Acquired Immune Deficiency Syndrome (AIDS). It is not known if SYMTUZA ® is safe and effective in children weighing less than 88 pounds (40 kg).
How do you know if you have a heart attack?
Tell your healthcare provider right away if you get these symptoms: weakness or being more tired than usual, unusual muscle pain, being short of breath or fast breathing, stomach pain with nausea and vomiting, cold or blue hands and feet, feel dizzy or lightheaded, or a fast or abnormal heartbeat.
What is Symtuza used for?
SYMTUZA ® is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 40 kg:
How long is the Symtuza trial?
Patients must be 12 years of age or older and have a valid, signed 30-day prescription. At the conclusion of the program, you and your patient decide if it is appropriate to continue treatment. Terms expire at the end of each calendar year and may change. This Trial Offer is open to patients who have commercial insurance, government coverage, or no insurance coverage; however, there is no guarantee of continuous accessibility after the program ends. Please refer to the SYMply Start ® Trial Offer brochure for program requirements or call Janssen CarePath at 877-CarePath (877-227-3728) to get a Trial Offer card for your patient.
How long to monitor hepatic function?
Action: Monitor hepatic function with both clinical and laboratory follow-up for at least several months in patients who are coinfected with HIV-1 and HBV and discontinue SYMTUZA ®. If appropriate, anti-hepatitis B therapy may be warranted.
What are the lab results for Symtuza?
Grade 2-4 laboratory abnormalities have been reported in patients receiving SYMTUZA ®, including elevations in serum creatinine , liver function tests, triglycerides, total cholesterol, low-density lipoproteins, and glucose levels. This is not a complete list of all adverse reactions reported with the use of SYMTUZA ®. Please refer to the full Prescribing Information for a complete list of adverse drug reactions.
Can you take Symtuza while pregnant?
Pregnancy: SYMTUZA ® is not recommended for use during pregnancy and should not be initiated in pregnant individuals because of substantially lower exposures of darunavir and cobicistat during pregnancy.
Does Tenofovir cause renal impairment?
New Onset or Worsening Renal Impairment: Postmarketing cases of renal impairment, including acute renal failure, proximal renal tubulopathy (PRT), and Fanconi syndrome have been reported with tenofovir alafenamide (TAF)-containing products; while most of these cases were characterized by potential confounders that may have contributed to the reported renal events, it is also possible these factors may have predisposed patients to tenofovir-related adverse events. SYMTUZA ® is not recommended in patients with estimated creatinine clearance below 30 mL per minute. Patients taking tenofovir prodrugs who have impaired renal function and those taking nephrotoxic agents including nonsteroidal anti-inflammatory drugs are at increased risk of developing renal-related adverse reactions.
Can Symtuza be discontinued?
Action: Discontinue SYMTUZA ® in any patient who develops clinical or laboratory findings suggestive of lactic acidosis or pronounced hepatotoxicity.
How much does Symtuza Janssen CarePath save?
Symtuza Janssen CarePath Savings Program: Most eligible commercially insured patients may pay $0 per fill on out-of-pocket costs with savings of up to $12,500 per calendar year; for additional assistance contact the program at 866-836-0114.
What is Symtuza used for?
Symtuza (cobicistat/darunavir/emtricitabine/tenofovir alafenamide) is a member of the antiviral combinations drug class and is commonly used for HIV Infection.
How much does a free drug card save?
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
How to contact the hospital access program?
This program allows eligible hospitals to receive free medications to give to qualified outpatients directly. Contact the program for more details (1-800-652-6227) . The hospital access application is only available via the online portal.
Is Symtuza a generic?
Symtuza is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Symtuza availability . This Symtuza price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Does Symtuza Janssen accept savings cards?
Symtuza Janssen CarePath Savings Program Rebate: Eligible commercially insured patients may submit a rebate request if the pharmacy does not accept the Savings Card; for additional assistance contact the program at 866-836-0114.
When there is a range of pricing, should consumers expect to pay the lower price?
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
What is Symtuza used for?
SYMTUZA ® is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 40 kg:
Is Symtuza safe for children?
Pediatric Use: The safety and effectiveness of SYMTUZA ® have not been established and is not recommended in pediatric patients weighing less than 40 kg .
Does Tenofovir cause renal impairment?
New Onset or Worsening Renal Impairment: Postmarketing cases of renal impairment, including acute renal failure, proximal renal tubulopathy (PRT), and Fanconi syndrome have been reported with tenofovir alafenamide (TAF)-containing products; while most of these cases were characterized by potential confounders that may have contributed to the reported renal events, it is also possible these factors may have predisposed patients to tenofovir-related adverse events. SYMTUZA ® is not recommended in patients with estimated creatinine clearance below 30 mL per minute. Patients taking tenofovir prodrugs who have impaired renal function and those taking nephrotoxic agents including nonsteroidal anti-inflammatory drugs are at increased risk of developing renal-related adverse reactions.
Can you take Symtuza while pregnant?
Pregnancy: SYMTUZA ® is not recommended for use during pregnancy and should not be initiated in pregnant individuals because of substantially lower exposures of darunavir and cobicistat during pregnancy.
Can Symtuza be discontinued?
Action: Discontinue SYMTUZA ® in any patient who develops clinical or laboratory findings suggestive of lactic acidosis or pronounced hepatotoxicity.
Can steatosis cause lactic acidosis?
Lactic Acidosis/Severe Hepatomegaly With Steatosis: Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogs, including emtricitabine, a component of SYMTUZA ®, and tenofovir disoproxil fumarate (TDF), another prodrug of tenofovir, alone or in combination with other antiretrovirals.
Does Darunavir have sulfonamide?
Sulfa Allergy: Darunavir contains a sulfonamide moiety. The incidence and severity of rash were similar in subjects with or without a history of sulfonamide allergy.
What is Symtuza used for?
SYMTUZA ® is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 40 kg:
How long to monitor hepatic function?
Action: Monitor hepatic function with both clinical and laboratory follow-up for at least several months in patients who are coinfected with HIV-1 and HBV and discontinue SYMTUZA ®. If appropriate, anti-hepatitis B therapy may be warranted.
What are the lab results for Symtuza?
Grade 2-4 laboratory abnormalities have been reported in patients receiving SYMTUZA ®, including elevations in serum creatinine , liver function tests, triglycerides, total cholesterol, low-density lipoproteins, and glucose levels. This is not a complete list of all adverse reactions reported with the use of SYMTUZA ®. Please refer to the full Prescribing Information for a complete list of adverse drug reactions.
What is Janssen CarePath Savings Program?
Janssen CarePath Savings Program may provide instant savings on your eligible patients' out-of-pocket costs for SY MTUZA ®. Depending on their health insurance plan, savings may apply toward co-pay, co-insurance, or deductible. For SYMTUZA ®, your eligible patients will pay $0 per prescription fill, with a $12,500 maximum program benefit per calendar year. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Terms expire at the end of each calendar year and may change. There is no income requirement. See full eligibility requirements .
What are the actions of antiretroviral therapy?
Action: Initiation or dose adjustments of insulin or oral hypoglycemic agents may be required. Fat Redistribution: Redistribution and/ or accumulation of body fat have been observed in patients receiving antiretroviral therapy. Hemophilia: Patients with hemophilia may develop an increase in bleeding events.
Can you take Symtuza while pregnant?
Pregnancy: SYMTUZA ® is not recommended for use during pregnancy and should not be initiated in pregnant individuals because of substantially lower exposures of darunavir and cobicistat during pregnancy.
Does Tenofovir cause renal impairment?
New Onset or Worsening Renal Impairment: Postmarketing cases of renal impairment, including acute renal failure, proximal renal tubulopathy (PRT), and Fanconi syndrome have been reported with tenofovir alafenamide (TAF)-containing products; while most of these cases were characterized by potential confounders that may have contributed to the reported renal events, it is also possible these factors may have predisposed patients to tenofovir-related adverse events. SYMTUZA ® is not recommended in patients with estimated creatinine clearance below 30 mL per minute. Patients taking tenofovir prodrugs who have impaired renal function and those taking nephrotoxic agents including nonsteroidal anti-inflammatory drugs are at increased risk of developing renal-related adverse reactions.
What are the lab results for Symtuza?
Grade 2-4 laboratory abnormalities have been reported in patients receiving SYMTUZA ®, including elevations in serum creatinine , liver function tests, triglycerides, total cholesterol, low-density lipoproteins, and glucose levels. This is not a complete list of all adverse reactions reported with the use of SYMTUZA ®. Please refer to the full Prescribing Information for a complete list of adverse drug reactions.
Is Symtuza safe for children?
Pediatric Use: The safety and effectiveness of SYMTUZA ® have not been established and is not recommended in pediatric patients weighing less than 40 kg .
Can steatosis cause lactic acidosis?
Lactic Acidosis/Severe Hepatomegaly With Steatosis: Lactic acidosis and severe hepatomegaly with steatosis, including fatal cases, have been reported with the use of nucleoside analogs, including emtricitabine, a component of SYMTUZA ®, and tenofovir disoproxil fumarate (TDF), another prodrug of tenofovir, alone or in combination with other antiretrovirals.
Can Symtuza be discontinued?
Action: Discontinue SYMTUZA ® in any patient who develops clinical or laboratory findings suggestive of lactic acidosis or pronounced hepatotoxicity.
Does Tenofovir cause renal impairment?
New Onset or Worsening Renal Impairment: Postmarketing cases of renal impairment, including acute renal failure, proximal renal tubulopathy (PRT), and Fanconi syndrome have been reported with tenofovir alafenamide (TAF)-containing products; while most of these cases were characterized by potential confounders that may have contributed to the reported renal events, it is also possible these factors may have predisposed patients to tenofovir-related adverse events. SYMTUZA ® is not recommended in patients with estimated creatinine clearance below 30 mL per minute. Patients taking tenofovir prodrugs who have impaired renal function and those taking nephrotoxic agents including nonsteroidal anti-inflammatory drugs are at increased risk of developing renal-related adverse reactions.
What are the actions of antiretroviral therapy?
Action: Initiation or dose adjustments of insulin or oral hypoglycemic agents may be required. Fat Redistribution: Redistribution and/ or accumulation of body fat have been observed in patients receiving antiretroviral therapy. Hemophilia: Patients with hemophilia may develop an increase in bleeding events.
Can you take Symtuza while pregnant?
Pregnancy: SYMTUZA ® is not recommended for use during pregnancy and should not be initiated in pregnant individuals because of substantially lower exposures of darunavir and cobicistat during pregnancy.
What is The Patient Assistance Program?
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, non-profit organization that is committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies.
Program Update
Patients may now choose the option of electronic income verification. Instead of submitting a copy of their Federal tax return, they can simply check a box on the updated application form.
